IN2014DN06198A - - Google Patents

Info

Publication number
IN2014DN06198A
IN2014DN06198A IN6198DEN2014A IN2014DN06198A IN 2014DN06198 A IN2014DN06198 A IN 2014DN06198A IN 6198DEN2014 A IN6198DEN2014 A IN 6198DEN2014A IN 2014DN06198 A IN2014DN06198 A IN 2014DN06198A
Authority
IN
India
Prior art keywords
tablet
present
tablets
hardness
eliminate
Prior art date
Application number
Inventor
Maria S Mirabile
Sandip G Shah
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of IN2014DN06198A publication Critical patent/IN2014DN06198A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Aspects of the present invention are directed to an oral antacid tablet comprising at least about 60% by weight directly compressible granulated calcium carbonate and an intense flavoring. The tablet may have a hardness of at least about 22 Strong Cobb units and the tablet may have a mass of between about 500 mg and about 1 000 mg. Tablets of the present invention reduce or eliminate heartburn symptoms and also freshen breath.
IN6198DEN2014 2012-02-02 2013-01-31 IN2014DN06198A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261594055P 2012-02-02 2012-02-02
PCT/US2013/024078 WO2013116477A1 (en) 2012-02-02 2013-01-31 Antacid tablet

Publications (1)

Publication Number Publication Date
IN2014DN06198A true IN2014DN06198A (en) 2015-10-23

Family

ID=48905820

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6198DEN2014 IN2014DN06198A (en) 2012-02-02 2013-01-31

Country Status (12)

Country Link
US (1) US20140037759A1 (en)
EP (1) EP2809331A4 (en)
CN (1) CN104136033A (en)
AR (1) AR089857A1 (en)
BR (1) BR112014019155A8 (en)
CA (1) CA2863389A1 (en)
CO (1) CO7020922A2 (en)
HK (1) HK1201179A1 (en)
IN (1) IN2014DN06198A (en)
MX (1) MX2014009391A (en)
WO (1) WO2013116477A1 (en)
ZA (1) ZA201405354B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
EP1596821A2 (en) * 2003-01-24 2005-11-23 The State Of Israel-Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
CA2514875A1 (en) * 2003-02-19 2004-09-02 Biovail Laboratories International Srl Rapid absorption selective 5-ht agonist formulations
UA95093C2 (en) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Method for the preparation of calcium-containing compound
WO2007134158A2 (en) * 2006-05-12 2007-11-22 Drugtech Corporation Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy

Also Published As

Publication number Publication date
HK1201179A1 (en) 2015-08-28
ZA201405354B (en) 2015-11-25
BR112014019155A2 (en) 2017-06-20
US20140037759A1 (en) 2014-02-06
CN104136033A (en) 2014-11-05
EP2809331A4 (en) 2015-07-15
EP2809331A1 (en) 2014-12-10
CA2863389A1 (en) 2013-08-08
AR089857A1 (en) 2014-09-24
CO7020922A2 (en) 2014-08-11
MX2014009391A (en) 2014-08-27
WO2013116477A1 (en) 2013-08-08
BR112014019155A8 (en) 2017-07-11

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
HK1147202A1 (en) Orally disintegrated dosage form
UA97489C2 (en) Pharmaceutical composition containing amorphous rosuvastatin calcium
UA92641C2 (en) Pharmaceutical composition comprising amlodipine and losartan
MY187718A (en) Pharmaceutical formulations
MX2009009153A (en) Pyrano-pyrazole-amines.
MX2017000827A (en) Sugar compositions for tableting by direct compression.
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2010001705A (en) Co-crystals of pyrimethanil and dithianon.
TN2012000507A1 (en) Enteric tablet
UA92077C2 (en) Orodispersible domperidone tablets
TN2010000585A1 (en) Pharmaceutical compositions of rosuvastatin calcium
IN2014MN01382A (en)
IN2014DN06198A (en)
MX2012002209A (en) Controlled-release formulations of anabaseine compounds and uses thereof.
ATE525064T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE
ES2482342A1 (en) Therapeutic treatment of t- and b-acute lymphoblastic leukemia and human lymphomas by inhibition of the interleukin-7 receptor (il-7r)
UA88127C2 (en) Tablet for prevention and treatment of dental and periodontium diseases
MX2011009844A (en) Pharmaceutical composition comprising aliskiren.
PH12019501070A1 (en) Sustained-release dosage forms of ruxolitinib
GR1007225B (en) Pharmaceutical composition of intestine-soluble tablets of trihydrate magnesium aspartate hydrochloride
UA105167C2 (en) Perindopril calcium salt or solvate thereof
MX2010000624A (en) Methods for promoting wakefulness.
UA99199C2 (en) Pharmaceutical compositions of rosuvastatin calcium